NCT07822464 Smoking Cessation in Patients With Cancer
| NCT ID | NCT07822464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nguyen Duc Khoa, MD, PhD |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 446 participants |
| Start Date | 2026-10-20 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 446 participants in total. It began in 2026-10-20 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial will evaluate whether adding one-session structured cognitive behavioral therapy (CBT)-based smoking-cessation counseling to standardized brief smoking-cessation counseling improves cigarette smoking abstinence among patients with cancer who smoked combustible cigarettes at diagnosis and are still smoking at screening and enrollment. After written informed consent and baseline assessment, all participants will receive the same standardized brief smoking-cessation counseling using a condensed 5A framework. Participants will then be randomly assigned 1:1 to no additional study CBT or to one additional structured CBT-based smoking-cessation session. Follow-up will continue for 3 months after randomization at Campus 3 of Vietnam National Cancer Hospital in Hanoi, Vietnam.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18 years or older. 2. Diagnosed with cancer. 3. Was smoking combustible cigarettes at the time of cancer diagnosis. 4. Still smoking combustible cigarettes at screening/enrollment. 5. Able to communicate sufficiently and provide reliable study information. 6. Provides written informed consent. Exclusion Criteria: 1. Clinically too severe for reliable participation. 2. Cognitive/communication limitations precluding consent or reliable participation. 3. Currently participating in a competing structured smoking-cessation program. 4. Concurrent use of tobacco/nicotine products other than combustible cigarettes (e-cigarette, heated tobacco product, waterpipe/shisha, cigar, pipe, smokeless tobacco, etc.). Outside therapeutic NRT/cessation medications are not an exclusion.
Contact & Investigator
Nguyen Duc Khoa, MD, PhD
PRINCIPAL INVESTIGATOR
Vietnam National Cancer Hospital
Frequently Asked Questions
Who can join the NCT07822464 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07822464 currently recruiting?
Yes, NCT07822464 is actively recruiting participants. Contact the research team at khoa8668@gmail.com for enrollment information.
Where is the NCT07822464 trial being conducted?
This trial is being conducted at Hanoi, Vietnam.
Who is sponsoring the NCT07822464 clinical trial?
NCT07822464 is sponsored by Nguyen Duc Khoa, MD, PhD. The principal investigator is Nguyen Duc Khoa, MD, PhD at Vietnam National Cancer Hospital. The trial plans to enroll 446 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.